IBDEI1F5.m

IBDEI1F5 ; ; 01-FEB-2022

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,22949,1,3,0)

 ;;=3^S/P Non-Melanoma Skin Cancer

 ;;^UTILITY(U,$J,358.3,22949,1,4,0)

 ;;=4^Z85.828

 ;;^UTILITY(U,$J,358.3,22949,2)

 ;;=^5063443

 ;;^UTILITY(U,$J,358.3,22950,0)

 ;;=Z85.820^^76^992^2

 ;;^UTILITY(U,$J,358.3,22950,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22950,1,3,0)

 ;;=3^S/P Melanoma

 ;;^UTILITY(U,$J,358.3,22950,1,4,0)

 ;;=4^Z85.820

 ;;^UTILITY(U,$J,358.3,22950,2)

 ;;=^5063441

 ;;^UTILITY(U,$J,358.3,22951,0)

 ;;=L57.8^^76^992^3

 ;;^UTILITY(U,$J,358.3,22951,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22951,1,3,0)

 ;;=3^Actinic Damage

 ;;^UTILITY(U,$J,358.3,22951,1,4,0)

 ;;=4^L57.8

 ;;^UTILITY(U,$J,358.3,22951,2)

 ;;=^5009226

 ;;^UTILITY(U,$J,358.3,22952,0)

 ;;=L57.0^^76^992^4

 ;;^UTILITY(U,$J,358.3,22952,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22952,1,3,0)

 ;;=3^Actinic Keratosis

 ;;^UTILITY(U,$J,358.3,22952,1,4,0)

 ;;=4^L57.0

 ;;^UTILITY(U,$J,358.3,22952,2)

 ;;=^66900

 ;;^UTILITY(U,$J,358.3,22953,0)

 ;;=D48.5^^76^992^5

 ;;^UTILITY(U,$J,358.3,22953,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22953,1,3,0)

 ;;=3^Neoplasm of Uncertain Behavior

 ;;^UTILITY(U,$J,358.3,22953,1,4,0)

 ;;=4^D48.5

 ;;^UTILITY(U,$J,358.3,22953,2)

 ;;=^267777

 ;;^UTILITY(U,$J,358.3,22954,0)

 ;;=L82.1^^76^992^6

 ;;^UTILITY(U,$J,358.3,22954,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22954,1,3,0)

 ;;=3^Seborrheic Keratosis

 ;;^UTILITY(U,$J,358.3,22954,1,4,0)

 ;;=4^L82.1

 ;;^UTILITY(U,$J,358.3,22954,2)

 ;;=^303312

 ;;^UTILITY(U,$J,358.3,22955,0)

 ;;=L82.0^^76^992^7

 ;;^UTILITY(U,$J,358.3,22955,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22955,1,3,0)

 ;;=3^Inflamed Seborrheic Keratosis

 ;;^UTILITY(U,$J,358.3,22955,1,4,0)

 ;;=4^L82.0

 ;;^UTILITY(U,$J,358.3,22955,2)

 ;;=^303311

 ;;^UTILITY(U,$J,358.3,22956,0)

 ;;=B07.9^^76^992^8

 ;;^UTILITY(U,$J,358.3,22956,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22956,1,3,0)

 ;;=3^Viral Wart

 ;;^UTILITY(U,$J,358.3,22956,1,4,0)

 ;;=4^B07.9

 ;;^UTILITY(U,$J,358.3,22956,2)

 ;;=^5000519

 ;;^UTILITY(U,$J,358.3,22957,0)

 ;;=D22.9^^76^992^9

 ;;^UTILITY(U,$J,358.3,22957,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22957,1,3,0)

 ;;=3^Mole/Melanocytic

 ;;^UTILITY(U,$J,358.3,22957,1,4,0)

 ;;=4^D22.9

 ;;^UTILITY(U,$J,358.3,22957,2)

 ;;=^5002058

 ;;^UTILITY(U,$J,358.3,22958,0)

 ;;=D23.9^^76^992^10

 ;;^UTILITY(U,$J,358.3,22958,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22958,1,3,0)

 ;;=3^Benign Neoplasm

 ;;^UTILITY(U,$J,358.3,22958,1,4,0)

 ;;=4^D23.9

 ;;^UTILITY(U,$J,358.3,22958,2)

 ;;=^5002076

 ;;^UTILITY(U,$J,358.3,22959,0)

 ;;=D18.01^^76^992^11

 ;;^UTILITY(U,$J,358.3,22959,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22959,1,3,0)

 ;;=3^Angioma

 ;;^UTILITY(U,$J,358.3,22959,1,4,0)

 ;;=4^D18.01

 ;;^UTILITY(U,$J,358.3,22959,2)

 ;;=^267697

 ;;^UTILITY(U,$J,358.3,22960,0)

 ;;=L24.89^^76^992^12

 ;;^UTILITY(U,$J,358.3,22960,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22960,1,3,0)

 ;;=3^Irritant Dermatitis

 ;;^UTILITY(U,$J,358.3,22960,1,4,0)

 ;;=4^L24.89

 ;;^UTILITY(U,$J,358.3,22960,2)

 ;;=^5009135

 ;;^UTILITY(U,$J,358.3,22961,0)

 ;;=L21.8^^76^992^13

 ;;^UTILITY(U,$J,358.3,22961,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22961,1,3,0)

 ;;=3^Seborrheic Dermatitis

 ;;^UTILITY(U,$J,358.3,22961,1,4,0)

 ;;=4^L21.8

 ;;^UTILITY(U,$J,358.3,22961,2)

 ;;=^303310

 ;;^UTILITY(U,$J,358.3,22962,0)

 ;;=L20.89^^76^992^14

 ;;^UTILITY(U,$J,358.3,22962,1,0)

 ;;=^358.31IA^4^2

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---IBDEI1F5   3753     printed  Feb 18, 2025@23:33:52                                                                                                                                                                                                    Page 2

IBDEI1F5  ; ; 01-FEB-2022

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 +2        if 'DIFQR(358.3)

               QUIT 

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT 

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT 

 +1       ;;^UTILITY(U,$J,358.3,22949,1,3,0)

 +2       ;;=3^S/P Non-Melanoma Skin Cancer

 +3       ;;^UTILITY(U,$J,358.3,22949,1,4,0)

 +4       ;;=4^Z85.828

 +5       ;;^UTILITY(U,$J,358.3,22949,2)

 +6       ;;=^5063443

 +7       ;;^UTILITY(U,$J,358.3,22950,0)

 +8       ;;=Z85.820^^76^992^2

 +9       ;;^UTILITY(U,$J,358.3,22950,1,0)

 +10      ;;=^358.31IA^4^2

 +11      ;;^UTILITY(U,$J,358.3,22950,1,3,0)

 +12      ;;=3^S/P Melanoma

 +13      ;;^UTILITY(U,$J,358.3,22950,1,4,0)

 +14      ;;=4^Z85.820

 +15      ;;^UTILITY(U,$J,358.3,22950,2)

 +16      ;;=^5063441

 +17      ;;^UTILITY(U,$J,358.3,22951,0)

 +18      ;;=L57.8^^76^992^3

 +19      ;;^UTILITY(U,$J,358.3,22951,1,0)

 +20      ;;=^358.31IA^4^2

 +21      ;;^UTILITY(U,$J,358.3,22951,1,3,0)

 +22      ;;=3^Actinic Damage

 +23      ;;^UTILITY(U,$J,358.3,22951,1,4,0)

 +24      ;;=4^L57.8

 +25      ;;^UTILITY(U,$J,358.3,22951,2)

 +26      ;;=^5009226

 +27      ;;^UTILITY(U,$J,358.3,22952,0)

 +28      ;;=L57.0^^76^992^4

 +29      ;;^UTILITY(U,$J,358.3,22952,1,0)

 +30      ;;=^358.31IA^4^2

 +31      ;;^UTILITY(U,$J,358.3,22952,1,3,0)

 +32      ;;=3^Actinic Keratosis

 +33      ;;^UTILITY(U,$J,358.3,22952,1,4,0)

 +34      ;;=4^L57.0

 +35      ;;^UTILITY(U,$J,358.3,22952,2)

 +36      ;;=^66900

 +37      ;;^UTILITY(U,$J,358.3,22953,0)

 +38      ;;=D48.5^^76^992^5

 +39      ;;^UTILITY(U,$J,358.3,22953,1,0)

 +40      ;;=^358.31IA^4^2

 +41      ;;^UTILITY(U,$J,358.3,22953,1,3,0)

 +42      ;;=3^Neoplasm of Uncertain Behavior

 +43      ;;^UTILITY(U,$J,358.3,22953,1,4,0)

 +44      ;;=4^D48.5

 +45      ;;^UTILITY(U,$J,358.3,22953,2)

 +46      ;;=^267777

 +47      ;;^UTILITY(U,$J,358.3,22954,0)

 +48      ;;=L82.1^^76^992^6

 +49      ;;^UTILITY(U,$J,358.3,22954,1,0)

 +50      ;;=^358.31IA^4^2

 +51      ;;^UTILITY(U,$J,358.3,22954,1,3,0)

 +52      ;;=3^Seborrheic Keratosis

 +53      ;;^UTILITY(U,$J,358.3,22954,1,4,0)

 +54      ;;=4^L82.1

 +55      ;;^UTILITY(U,$J,358.3,22954,2)

 +56      ;;=^303312

 +57      ;;^UTILITY(U,$J,358.3,22955,0)

 +58      ;;=L82.0^^76^992^7

 +59      ;;^UTILITY(U,$J,358.3,22955,1,0)

 +60      ;;=^358.31IA^4^2

 +61      ;;^UTILITY(U,$J,358.3,22955,1,3,0)

 +62      ;;=3^Inflamed Seborrheic Keratosis

 +63      ;;^UTILITY(U,$J,358.3,22955,1,4,0)

 +64      ;;=4^L82.0

 +65      ;;^UTILITY(U,$J,358.3,22955,2)

 +66      ;;=^303311

 +67      ;;^UTILITY(U,$J,358.3,22956,0)

 +68      ;;=B07.9^^76^992^8

 +69      ;;^UTILITY(U,$J,358.3,22956,1,0)

 +70      ;;=^358.31IA^4^2

 +71      ;;^UTILITY(U,$J,358.3,22956,1,3,0)

 +72      ;;=3^Viral Wart

 +73      ;;^UTILITY(U,$J,358.3,22956,1,4,0)

 +74      ;;=4^B07.9

 +75      ;;^UTILITY(U,$J,358.3,22956,2)

 +76      ;;=^5000519

 +77      ;;^UTILITY(U,$J,358.3,22957,0)

 +78      ;;=D22.9^^76^992^9

 +79      ;;^UTILITY(U,$J,358.3,22957,1,0)

 +80      ;;=^358.31IA^4^2

 +81      ;;^UTILITY(U,$J,358.3,22957,1,3,0)

 +82      ;;=3^Mole/Melanocytic

 +83      ;;^UTILITY(U,$J,358.3,22957,1,4,0)

 +84      ;;=4^D22.9

 +85      ;;^UTILITY(U,$J,358.3,22957,2)

 +86      ;;=^5002058

 +87      ;;^UTILITY(U,$J,358.3,22958,0)

 +88      ;;=D23.9^^76^992^10

 +89      ;;^UTILITY(U,$J,358.3,22958,1,0)

 +90      ;;=^358.31IA^4^2

 +91      ;;^UTILITY(U,$J,358.3,22958,1,3,0)

 +92      ;;=3^Benign Neoplasm

 +93      ;;^UTILITY(U,$J,358.3,22958,1,4,0)

 +94      ;;=4^D23.9

 +95      ;;^UTILITY(U,$J,358.3,22958,2)

 +96      ;;=^5002076

 +97      ;;^UTILITY(U,$J,358.3,22959,0)

 +98      ;;=D18.01^^76^992^11

 +99      ;;^UTILITY(U,$J,358.3,22959,1,0)

 +100     ;;=^358.31IA^4^2

 +101     ;;^UTILITY(U,$J,358.3,22959,1,3,0)

 +102     ;;=3^Angioma

 +103     ;;^UTILITY(U,$J,358.3,22959,1,4,0)

 +104     ;;=4^D18.01

 +105     ;;^UTILITY(U,$J,358.3,22959,2)

 +106     ;;=^267697

 +107     ;;^UTILITY(U,$J,358.3,22960,0)

 +108     ;;=L24.89^^76^992^12

 +109     ;;^UTILITY(U,$J,358.3,22960,1,0)

 +110     ;;=^358.31IA^4^2

 +111     ;;^UTILITY(U,$J,358.3,22960,1,3,0)

 +112     ;;=3^Irritant Dermatitis

 +113     ;;^UTILITY(U,$J,358.3,22960,1,4,0)

 +114     ;;=4^L24.89

 +115     ;;^UTILITY(U,$J,358.3,22960,2)

 +116     ;;=^5009135

 +117     ;;^UTILITY(U,$J,358.3,22961,0)

 +118     ;;=L21.8^^76^992^13

 +119     ;;^UTILITY(U,$J,358.3,22961,1,0)

 +120     ;;=^358.31IA^4^2

 +121     ;;^UTILITY(U,$J,358.3,22961,1,3,0)

 +122     ;;=3^Seborrheic Dermatitis

 +123     ;;^UTILITY(U,$J,358.3,22961,1,4,0)

 +124     ;;=4^L21.8

 +125     ;;^UTILITY(U,$J,358.3,22961,2)

 +126     ;;=^303310

 +127     ;;^UTILITY(U,$J,358.3,22962,0)

 +128     ;;=L20.89^^76^992^14

 +129     ;;^UTILITY(U,$J,358.3,22962,1,0)

 +130     ;;=^358.31IA^4^2